45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
34,480
Insurances with rates
40
CPT / HCPCS codes
12,437
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 510020263 | vutrisiran 25 mg/0.5 mL syringe | $424,154 | $161,178 | — | — | 12 |
| 510020263 | vutrisiran 25 mg/0.5 mL syringe | $424,154 | $161,178 | — | — | 20 |
| 510020266 | lumasiran 94.5 mg/0.5 mL inj | $407,533 | $154,863 | — | — | 12 |
| 510020266 | lumasiran 94.5 mg/0.5 mL inj | $407,533 | $154,863 | — | — | 20 |
| 510020195 | tebentafusp-tebn 100 mcg/0.5 mL inj | $193,897 | $73,681 | — | — | 12 |
| 510020195 | tebentafusp-tebn 100 mcg/0.5 mL inj | $193,897 | $73,681 | — | — | 20 |
| 510018653 | tagraxofusp-erzs (Elzonris) 1000 mcg inj | $160,682 | $61,059 | — | — | 12 |
| 510018653 | tagraxofusp-erzs (Elzonris) 1000 mcg inj | $160,682 | $61,059 | — | — | 20 |
| 510013649 | ustekinumab 45 mg/0.5 mL inj | $135,292 | $51,411 | — | — | 12 |
| 510013649 | ustekinumab 45 mg/0.5 mL inj | $135,292 | $51,411 | — | — | 20 |
| 510013713 | ustekinumab 90 mg/1 mL inj | $135,292 | $51,411 | — | — | 12 |
| 510013713 | ustekinumab 90 mg/1 mL inj | $135,292 | $51,411 | — | — | 20 |
| 510020157 | loncastuximab tesirine-lpyl 10 mg inj | $132,168 | $50,224 | — | — | 12 |
| 510020157 | loncastuximab tesirine-lpyl 10 mg inj | $132,168 | $50,224 | — | — | 20 |
| 440080914 | GEN PULSE V INSP 3150 | $129,600 | $49,248 | — | — | 12 |
| 440080914 | GEN PULSE V INSP 3150 | $129,600 | $49,248 | — | — | 20 |
| 510020127 | lanreotide 90 mg syringe | $127,939 | $48,617 | — | — | 12 |
| 510020127 | lanreotide 90 mg syringe | $127,939 | $48,617 | — | — | 20 |
| 440077063 | LEAD STIM INSP 4063-45CM | $126,750 | $48,165 | — | — | 12 |
| 440077063 | LEAD STIM INSP 4063-45CM | $126,750 | $48,165 | — | — | 20 |
| 510017501 | ribavirin 6,000 mg Inhalation powder | $118,816 | $45,150 | — | — | 12 |
| 510017501 | ribavirin 6,000 mg Inhalation powder | $118,816 | $45,150 | — | — | 20 |
| 510016295 | alemtuzumab (Lemtrada) 12 mg/1.2 mL inj | $115,661 | $43,951 | — | — | 12 |
| 510016295 | alemtuzumab (Lemtrada) 12 mg/1.2 mL inj | $115,661 | $43,951 | — | — | 20 |
| 440059540 | GENRTR NRSTM 49.5X55.5M 3660ANS | $111,450 | $42,351 | — | — | 12 |
| 440059540 | GENRTR NRSTM 49.5X55.5M 3660ANS | $111,450 | $42,351 | — | — | 20 |
| 440077062 | GEN PULSE IV INSP 3028 | $109,350 | $41,553 | — | — | 12 |
| 440077062 | GEN PULSE IV INSP 3028 | $109,350 | $41,553 | — | — | 20 |
| 510018575 | inotuzumab ozogamicin 0.9 mg inj | $108,442 | $41,208 | — | — | 12 |
| 510018575 | inotuzumab ozogamicin 0.9 mg inj | $108,442 | $41,208 | — | — | 20 |
| 440081416 | GENERAT WAVEWRIT 16 SC-1216 | $103,800 | $39,444 | — | — | 12 |
| 440081416 | GENERAT WAVEWRIT 16 SC-1216 | $103,800 | $39,444 | — | — | 20 |
| 440059084 | SENSOR MRI INTELLIS 97715 | $101,640 | $38,623 | — | — | 12 |
| 440059084 | SENSOR MRI INTELLIS 97715 | $101,640 | $38,623 | — | — | 20 |
| 440063210 | STIM NRV WAVEWRITER SC-1416 | $97,800 | $37,164 | — | — | 12 |
| 440063210 | STIM NRV WAVEWRITER SC-1416 | $97,800 | $37,164 | — | — | 20 |
| 510017419 | porfimer 75 mg Inj | $97,233 | $36,948 | — | — | 12 |
| 510017419 | porfimer 75 mg Inj | $97,233 | $36,948 | — | — | 20 |
| 440080893 | SPYRAL DEN CATH RDN016 | $96,000 | $36,480 | — | — | 12 |
| 440080893 | SPYRAL DEN CATH RDN016 | $96,000 | $36,480 | — | — | 20 |
| 510018667 | polatuzumab vedotin-piiq 140 mg inj | $88,103 | $33,479 | — | — | 12 |
| 510018667 | polatuzumab vedotin-piiq 140 mg inj | $88,103 | $33,479 | — | — | 20 |
| 510018741 | fluocinolone acetonide intravitreal 0.59 mg implant | $86,870 | $33,011 | — | — | 12 |
| 510018741 | fluocinolone acetonide intravitreal 0.59 mg implant | $86,870 | $33,011 | — | — | 20 |
| 510018748 | teprotumumab-trbw (Tepezza) 500 mg inj | $85,307 | $32,417 | — | — | 12 |
| 510018748 | teprotumumab-trbw (Tepezza) 500 mg inj | $85,307 | $32,417 | — | — | 20 |
| 510016458 | vinCRIStine liposome 5 mg/31 mL kit | $74,553 | $28,330 | — | — | 12 |
| 510016458 | vinCRIStine liposome 5 mg/31 mL kit | $74,553 | $28,330 | — | — | 20 |
| 440061030 | PUMP SYNCH III 20ML 8667-20 | $68,610 | $26,072 | — | — | 12 |
| 440061030 | PUMP SYNCH III 20ML 8667-20 | $68,610 | $26,072 | — | — | 20 |
Showing top 50 of 34,480 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.